Expression of Intragenic LCAL4 Long Non-Coding RNAs as a Potential Diagnostic and Prognostic Marker in Female Breast Cancer

  • 0Department of Biology, School of Sciences, University of Tehran, Tehran, Iran.

|

|

Summary

This summary is machine-generated.

Long non-coding RNA LCAL4 shows distinct expression patterns in breast cancer subtypes and stages. This finding supports LCAL4 as a potential biomarker for early breast cancer detection and diagnosis.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background

  • Early detection of breast cancer is crucial for reducing mortality.
  • Long non-coding RNAs (LncRNAs) are promising biomarkers due to their specificity and accessibility.
  • Aberrant LncRNA expression is observed in various pathological conditions, including cancer.

Purpose Of The Study

  • To investigate the expression profile of intragenic non-coding LncRNA LCAL4.
  • To evaluate LCAL4 as a potential diagnostic and prognostic biomarker for breast cancer.

Main Methods

  • Real-time PCR was used to analyze gene expression.
  • 62 breast cancer tissue samples and normal peripheral tissues were analyzed.
  • Samples were obtained from patients undergoing therapeutic surgery.

Main Results

  • LCAL4 expression significantly differed between healthy controls and breast cancer subtypes.
  • Significant differences in LCAL4 expression were observed across different cancer subgroups and stages.
  • The expression pattern of LCAL4 indicates its potential role in distinguishing tumor from healthy tissue.

Conclusions

  • LncRNA LCAL4 can serve as a diagnostic marker for breast cancer.
  • The expression levels of LCAL4 correlate with cancer grades and subtypes.
  • LCAL4 may play an influential role in breast cancer progression and can be a valuable tool for diagnosis.